Skye Bioscience Inc - ESG Rating & Company Profile powered by AI
This page displays a zero-cost Sustainability report covering Skye Bioscience Inc. If you work at Skye Bioscience Inc and you would like to licence your Sustainability rating, please contact us. The ESG assessment for Skye Bioscience Inc indicates its reporting of the United Nations Sustainable Development Goals.
Skye Bioscience Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 3.2, social score of 6.0 and governance score of 6.0.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Skye Bioscience Inc have an accelerator or VC vehicle to help deliver innovation?
Does Skye Bioscience Inc disclose current and historical energy intensity?
Does Skye Bioscience Inc report the average age of the workforce?
Does Skye Bioscience Inc reference operational or capital allocation in relation to climate change?
Does Skye Bioscience Inc disclose its ethnicity pay gap?
Does Skye Bioscience Inc disclose cybersecurity risks?
Does Skye Bioscience Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Skye Bioscience Inc offer flexible work?
Does Skye Bioscience Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Skye Bioscience Inc disclose the number of employees in R&D functions?
Does Skye Bioscience Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Skye Bioscience Inc conduct supply chain audits?
Does Skye Bioscience Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Skye Bioscience Inc conduct 360 degree staff reviews?
Does Skye Bioscience Inc disclose the individual responsible for D&I?
Does Skye Bioscience Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Skye Bioscience Inc disclose current and / or historical scope 2 emissions?
Does Skye Bioscience Inc disclose water use targets?
Does Skye Bioscience Inc have careers partnerships with academic institutions?
Did Skye Bioscience Inc have a product recall in the last two years?
Does Skye Bioscience Inc disclose incidents of discrimination?
Does Skye Bioscience Inc allow for Work Councils/Collective Agreements to be formed?
Has Skye Bioscience Inc issued a profit warning in the past 24 months?
Does Skye Bioscience Inc disclose parental leave metrics?
Does Skye Bioscience Inc disclose climate scenario or pathway analysis?
Does Skye Bioscience Inc disclose current and / or historical scope 1 emissions?
Does Skye Bioscience Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Skye Bioscience Inc disclose the pay ratio of women to men?
Does Skye Bioscience Inc support suppliers with sustainability related research and development?
Does Skye Bioscience Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Skye Bioscience Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Skye Bioscience Inc involved in embryonic stem cell research?
Does Skye Bioscience Inc disclose GHG and Air Emissions intensity?
Does Skye Bioscience Inc disclose its waste policy?
Does Skye Bioscience Inc report according to TCFD requirements?
Does Skye Bioscience Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Skye Bioscience Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Skye Bioscience Inc disclose energy use targets?
Does Skye Bioscience Inc disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does Skye Bioscience Inc have a policy relating to cyber security?
Potential Risks for Skye Bioscience Inc
These potential risks are based on the size, segment and geographies of the company.
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based therapeutics for the treatment of infectious diseases. The company's lead product candidate is THCVHS, which is in preclinical trials for the treatment of glaucoma. It is also developing CBDVHS that is in preclinical trials to treat various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and Cannabinoid Cocktail for the treatment of anti-infective diseases. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.